Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab

PURPOSE: Real-world data and study data regarding therapy with Emicizumab in pediatric cohorts with haemophilia A is scarce. Especially, data on previously untreated pediatric patients (PUPs) and minimally treated patients (MTPs) are missing. METHODS: Thirteen pediatric patients with haemophilia A a...

Descripción completa

Detalles Bibliográficos
Autores principales: Glonnegger, Hannah, Andresen, Felicia, Kapp, Friedrich, Malvestiti, Stefano, Büchsel, Martin, Zieger, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377120/
https://www.ncbi.nlm.nih.gov/pubmed/35965332
http://dx.doi.org/10.1186/s12887-022-03546-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377120/
https://www.ncbi.nlm.nih.gov/pubmed/35965332
http://dx.doi.org/10.1186/s12887-022-03546-1

Ejemplares similares